Floatz logo

107 assets in Malignant Glioma

Therapeutic assets addressing Malignant Glioma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Ntx-301
Malignant Glioma
Xennials Therapeutics Australia Pty LtdP1/2CC (47)
Paxalisib
Malignant Glioma
Institute of Cancer Research, United KingdomP1/2CC (47)
Abemaciclib
Malignant Glioma
Tango Therapeutics, Inc.P1/2CC (45)
Amxt1501
Malignant Glioma
Aminex Therapeutics, Inc.P1/2CC (45)
Eflornithine
Malignant Glioma
Mayo ClinicP1/2CC (45)
LMP744
Malignant Glioma
National Institute of Neurological Disorders and Stroke (NINDS)P1/2CC (45)
Retifanlimab
Malignant Glioma
Mayo ClinicP1/2CC (45)
tng456
Malignant Glioma
Tango Therapeutics, Inc.P1/2CC (45)
Abexinostat
Malignant Glioma
University of NebraskaP1CC (43)
Amivantamab-Vmjw
Malignant Glioma
Institute of Cancer Research, United KingdomP1CC (43)
Arm 1: Il13Ra2-Specific Car Tcm Cells
Malignant Glioma
City of Hope Medical CenterP1CC (43)
Arm 2: Il13Ra2-Specific Car Tcm Cells
Malignant Glioma
City of Hope Medical CenterP1CC (43)
Arm 3: Il13Ra2-Specific Car Tcm Cells
Malignant Glioma
City of Hope Medical CenterP1CC (43)
Arm 4: Il13Ra2-Specific Car Tcm Cells
Malignant Glioma
City of Hope Medical CenterP1CC (43)
Azeliragon
Malignant Glioma
NYU Langone HealthP1CC (43)
Bicalutamide
Malignant Glioma
University of NebraskaP1CC (43)
c134
Malignant Glioma
University of Alabama at BirminghamP1CC (43)
Carboxylesterase-Expressing Allogeneic Neural Stem Cells
Malignant Glioma
City of Hope Medical CenterP1CC (43)
Cetuximab-Irdye800
Malignant Glioma
University Medical Center GroningenP1CC (43)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes
Malignant Glioma
City of Hope Medical CenterP1CC (43)
Claturafenib
Malignant Glioma
PfizerP1CC (43)
Definity
Malignant Glioma
Sunnybrook Health Sciences CentreP1CC (43)
Dual-Target Car-Nk Cells
Malignant Glioma
Beijing BiotechP1CC (43)
Ex-Vivo Expanded Autologous Il-8 Receptor Modified Cd70 Car T Cells
Malignant Glioma
University of FloridaP1CC (43)
ik-595
Malignant Glioma
Ikena OncologyP1CC (43)
Oncolytic Adenovirus Ad5-Dnx-2401
Malignant Glioma
M.D. Anderson Cancer CenterP1CC (43)
pf-07799544
Malignant Glioma
PfizerP1CC (43)
Sitagliptin
Malignant Glioma
Kailin Yang, MD, PhDP1CC (43)
18f-trx
Malignant Glioma
Rahul AggarwalP1CC (41)
2141-v11
Malignant Glioma
Darell BignerP1CC (41)
b7-h3-car t cells
Malignant Glioma
St. Jude Children's Research HospitalP1CC (41)
Carv3-Team-E T Cells
Malignant Glioma
Marcela V. Maus, M.D.,Ph.D.P1CC (41)
CD19t
Malignant Glioma
City of Hope Medical CenterP1CC (41)
Cue-102
Malignant Glioma
David Reardon, MDP1CC (41)
d2c7-it
Malignant Glioma
Darell BignerP1CC (41)
Dexasone
Malignant Glioma
City of Hope Medical CenterP1CC (41)
Evolocumab
Malignant Glioma
Duke UniversityEarly P1CC (41)
Fb-Pmt
Malignant Glioma
NanoPharmaceuticals LLCP1CC (41)
her2bbζ/cd19t+ t cells
Malignant Glioma
City of Hope Medical CenterP1CC (41)
HER2(EQ)BBzeta
Malignant Glioma
City of Hope Medical CenterP1CC (41)
mt-201-gbm monocyte vaccine
Malignant Glioma
Michael GunnP1CC (41)
Pamiparib
Malignant Glioma
University of California, San FranciscoP1CC (41)
ts-2021
Malignant Glioma
Beijing Neurosurgical InstituteP1CC (41)
Tumor Associated Antigen Peptide Vaccine P30-Eps Vaccine
Malignant Glioma
Mustafa Khasraw, MBChB, MD, FRCP, FRACPP1CC (41)
Umitrelimorgene Autodencel Human Lysosomal Associated Membrane Protein 1/Human Cytomegalovirus (Hcmv) 65 Kda Matrix Protein Mrna
Malignant Glioma
University of FloridaP1CC (41)
[177lu]lu-dota-eb-rgd2
Malignant Glioma
Beijing Tiantan HospitalEarly P1C (39)
Fimepinostat
Malignant Glioma
Sabine Mueller, MD, PhDEarly P1C (39)
azd1390
Malignant Glioma
Nader SanaiEarly P1C (38)
Bdtx-1535
Malignant Glioma
St. Joseph's Hospital and Medical Center, PhoenixEarly P1C (38)
Dsp-0390
Malignant Glioma
Sumitomo Pharma America, Inc.Early P1C (38)
Showing 51 to 100 of 107 assets
PreviousPage 2 of 3Next